SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-146584
Filing Date
2019-05-14
Accepted
2019-05-14 16:30:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d738747dsc13d.htm SC 13D 65494
  Complete submission text file 0001193125-19-146584.txt   67044
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: SC 13D | Act: 34 | File No.: 005-91001 | Film No.: 19823196
SIC: 2834 Pharmaceutical Preparations